SCPrimary vaccinationPatient ≥9 mth 0.5 mL single inj. BoosterChildn up to 18 yr 0.5 mL dose 12-24 mth after primary vaccination. Childn previously given an inactivated Japanese encephalitis vaccine for primary vaccination 0.5 mL as booster dose in accordance w/ the recommended timing for the booster of the inactivated Japanese encephalitis vaccine. Patient ≥2 yr Inj in the deltoid region of the upper arm. Patient 9-24 mth Inj in the anterolateral aspect of the thigh or the deltoid region.
View Imojev overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity to the vaccine or after previous inj. Postpone vaccination in case of febrile or acute disease. Congenital or acquired immune deficiency impairing cellular immunity including immunosuppressive therapies eg, chemotherapy & high doses of systemic corticosteroids given for ≥14 days. Symptomatic or asymptomatic HIV-infected patient w/ evidence of impaired immune function. Pregnancy & lactation.
Do not administer intravascularly. Treatment w/ high doses of systemic corticosteroids given for ≥14 days should wait at least ≥1 mth before vaccination. Not to be mixed w/ any other inj vaccine(s) or medicinal product(s).
Separate inj sites & syringe when other vaccines are concomitantly administered. Concomitant use w/ immunosuppressive or corticosteroid therapy. Vaccination must not be performed w/in 6 wk & not w/in 3 mth of Ig inj or blood products containing Ig eg, blood or plasma.
Sign Out
cf2d9be9-5985-41ee-ad2f-a73e00774322.GIF)
